New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia

Clinical trial NCT06944145 · RECRUITING

Trial details

NCT number: NCT06944145
Sponsor: Beth Israel Deaconess Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

BPH (Benign Prostatic Hyperplasia)Lower Urinary Track Symptoms

Start date: 2025-12-03
Primary completion: 2029-06-01
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.